NCT03507322

Brief Summary

This study is focused on analysing the application of ultrasound scanning techniques as new biomarkers in reproductive medicine. Those biomarkers are based on the analysis of ultrasound texture in different areas of uterine tissue, using 2D/3D ultrasound scanning. Investigators will use the algorithm Text® to analyse the ultrasound texture of the endometrium and myometrium. The aim of the project is to study if it is possible to obtain measurable, objective and reproducible data in healthy volunteers which can be used to predict pregnancy and determine the best moment to perform embryo transfer in assisted reproductive technology (ART) cycles

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Nov 2017

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 7, 2017

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

November 10, 2017

Completed
6 months until next milestone

First Posted

Study publicly available on registry

April 25, 2018

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 10, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 10, 2018

Completed
Last Updated

September 12, 2018

Status Verified

September 1, 2018

Enrollment Period

10 months

First QC Date

November 10, 2017

Last Update Submit

September 10, 2018

Conditions

Keywords

texturizationpregnancy rateoocyte donation2D ultrasound3D ultrasoundassisted reproductive technology (ART)

Outcome Measures

Primary Outcomes (5)

  • Clinical pregnancy rate

    Detection of gestational sac through ultrasound scanning indicating clinical pregnancy

    Around 5-6 weeks after embryo transfer

  • Biochemical miscarriage rate

    Interruption of pregnancy after a positive result in the beta HCG test

    Up to one month after embryo transfer

  • Clinical miscarriage rate

    Interruption of pregnancy after confirming clinical pregnancy using ultrasound scanning

    Up to 20 weeks after embryo transfer

  • Chemical pregnancy rate

    Positive result in beta HCG test indicating pregnancy

    Around 14 days after embryo transfer

  • beta HCG level

    Level of beta HCG in the test performed to detect pregnancy

    Around 14 days after embryo transfer

Study Arms (1)

Ultrasound texturization

Application of ultrasound texturization (2D/3D ultrasound scanning)

Other: Ultrasound texturization

Interventions

Along several visits to the clinic, the patients will be subjected to 2D/3D ultrasound scanning.

Ultrasound texturization

Eligibility Criteria

Age18 Years - 49 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Infertile women undergoing IVF/ICSI treatment

You may qualify if:

  • Body mass index (BMI) between 18 and 30 kg/m2
  • Not taking the contraceptive pill in a previous cycle
  • Non-pregnant: beta human chorionic gonadotropin (HCG) test with negative result at the beginning of the study)
  • No previous history of inflammatory diseases, circulatory diseases, abdomen or pelvic diseases
  • Physical gynecological exploration without pathological findings
  • Gynecological ultrasound study of the uterus with a normal result

You may not qualify if:

  • Ultrasound studies with technical defects in image acquisition
  • Simultaneous participation in other studies
  • Previous participation in other study which can affect the results of the present study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IVI Sevilla

Seville, 41011, Spain

Location

MeSH Terms

Conditions

Infertility

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital Diseases
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 10, 2017

First Posted

April 25, 2018

Study Start

November 7, 2017

Primary Completion

September 10, 2018

Study Completion

September 10, 2018

Last Updated

September 12, 2018

Record last verified: 2018-09

Locations